2 Dirt Cheap Dividend Stocks You Can Buy Right Now
What's better than purchasing shares of a strong dividend-paying company? Answer: Purchasing shares of a strong dividend-paying company trading at a bargain. Although today's market looks overvalued, reasonably priced options do exist for income-oriented investors. Two that fit the bill are pharma giants Bristol Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE).
The former boasts a forward price to earnings ratio of 9.0. Meanwhile, Pfizer's forward P/E stands at 11.0. For reference, the forward P/E for the pharmaceuticals industry was 14.3 as of July 19. And these two companies have more to offer dividend-seeking investors than just their relatively attractive valuation figures. Let's see why both would be a fine addition to a dividend portfolio.
Image source: Getty Images.
Source Fool.com
